CHRISTINA WOOD: Open Payments
NPI 1346526498 · CALLICOON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 40 payments from 9 companies in 2025. Trend: 2023 $347 · 2024 $651 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $269 |
| Otsuka America Pharmaceutical, Inc. | 6 | $124 |
| Novo Nordisk Inc | 5 | $111 |
| PFIZER INC. | 4 | $91 |
| ABBVIE INC. | 3 | $76 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Boston Scientific Corporation | 1 | $53 |
| Exact Sciences Corporation | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: BREZTRI, REXULTI, Wegovy, VRAYLAR, ELIQUIS, TRELEGY ELLIPTA, AIRSUPRA, FARAPULSE.
Industry payments across NY — which companies pay providers there.
